Scientific Sense ®

Latest Episodes:

Prof. Julia Lane, Professor at NYU Wagner Graduate School of Public Service Jun 03, 2020

Show notes

Democratizing our data - A manifesto. Improving the design of metrics, collection of data, analysis and decision-making at the federal level

Prof. Julia Lane is a Professor at the New York University Wagner Graduate School of Public Service and an NYU Fellow for Innovation Analytics. She is a senior advisor in the Office of the Federal CIO at the White House, supporting the implementation of the Federal Data Strategy. She cofounded the Coleridge Initiative, whose goal is to use data to transform the way governments access and use data for the social good through training programs, research projects, and a secure data facility.

Dr. Ian Williams, author, sculptor and biochemist. May 30, 2020

Show notes

Humans, bacteria, intelligence, consciousness, life and everything else

Ian Williams was born in England in 1954. He trained as a biochemist at the Universities of Bristol and Oxford and received an MFA from Bennington College in Vermont. He worked for Pfizer for twenty years heading the Molecular Sciences Department and serving in the Research strategy group. He and his wife, Nancy Hutson, have a farm in Connecticut containing over 50 large-scale sculptures that Williams has made over the last decade. Together with Nancy, he has ridden in horseback safaris in many parts of the world. He may be reached at ian.inc@mac.com

Dr.Pierre Etienne, co-Director of the Alzheimer’s disease prevention program at McGill University May 24, 2020

Show notes

COVID-19, clinical trial processes, pharmaceutical R&D, vaccine development, use of preventative medications, Alzheimer's disease, PTSD

After obtaining his medical degree in Belgium in 1972, Pierre Etienne moved to McGill University, where he did postgraduate work in neurochemistry. There he directed a program on the biochemical, physiological, and neuropathological basis of Alzheimer's disease. After a brief passage in experimental medicine at Ciba-Geigy (now Novartis), he went back to McGill in 1987, dividing his time between the Montreal Neurological Institute and the Allan Memorial Institute. In 1989 he joined Pfizer as Director of Experimental Medicine, responsible for all Phase 2 A programs for US and Japan discovered compounds. In 2003, he became CEO of PhageTech, Inc., a privately-held biotechnology company based in Montreal, Canada. PhageTech exploited a proprietary platform based on phage-bacterial intracellular interactions to research and develop new classes of synthetic antibiotics. Phagetech later became Targanta Therapeutics that went public on NASDAQ (TARG) in the summer of 2008. In December 2009, he started a new life as a physician at the Douglas Institute. In July 2011, he was appointed Director of the Clinical Research Division. He is the co-Director of the Alzheimer’s disease prevention program (Stop-AD).

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

Scientific Sense ®

Related Podcasts

1

2

3

4

5

6